Uganda Health News API

{
    "totalArticles": 2247,
    "articles": [
        {
            "id": "5a0ac198f61bc0511923e0d3283bf478",
            "title": "Shifting Paradigms in the Surgical and Systemic Management of RCC",
            "description": "Patrick A. Kenney, MD, and David A. Braun, MD, PhD, discussed parameters they use to determine a patient’s eligibility for cytoreductive nephrectomy.",
            "content": "In an interview with CancerNetwork®, Patrick A. Kenney, MD, and David A. Braun, MD, PhD, came together to discuss keen insights into the surgical and systemic management of renal cell carcinoma (RCC), particularly covering key topics such as selectio... [10070 chars]",
            "url": "https://www.cancernetwork.com/view/shifting-paradigms-in-the-surgical-and-systemic-management-of-rcc",
            "image": "https://cdn.sanity.io/images/0vv8moc6/cancernetwork/107aea768d8832c86719486116743591790907fd-1200x1350.jpg",
            "publishedAt": "2026-04-23T20:09:19Z",
            "lang": "en",
            "source": {
                "id": "5aa24e4b1a0873860bbc7102ec053fb0",
                "name": "CancerNetwork",
                "url": "https://www.cancernetwork.com"
            }
        },
        {
            "id": "c91f7fb2d216a19f8eca7c7b1f48f239",
            "title": "TRIDENT: Triple Antihypertensive Pill Cuts Recurrent Stroke in ICH",
            "description": "The strategy provides a new therapeutic option in a setting where BP control is vital but remains suboptimal.",
            "content": "A single pill combining three antihypertensive agents at low doses reduces blood pressure and recurrent stroke risk when added to standard care in patients with a history of intracerebral hemorrhage (ICH), results of the randomized TRIDENT trial show... [6167 chars]",
            "url": "https://www.tctmd.com/news/trident-triple-antihypertensive-pill-cuts-recurrent-stroke-ich",
            "image": "https://d14d5nk8lue86f.cloudfront.net/s3fs-public/2026-04/TRIDENT%20Triple%20Antihypertensive%20Pill%20Cuts%20Recurrent%20Stroke%20in%20ICH.jpg",
            "publishedAt": "2026-04-23T19:30:00Z",
            "lang": "en",
            "source": {
                "id": "6f1cf3918c9974e771cdda266d6941f0",
                "name": "TCTMD.com",
                "url": "https://www.tctmd.com"
            }
        },
        {
            "id": "1fe7611affc41f1fdfcd5184fc15a2ff",
            "title": "ESCMID Global 2026: Adibelivir emerges as potential disease",
            "description": "Innovative Molecules' adibelivir had a favourable pharmacokinetic profile and proved safe and efficacious in Phase I clinical trials.",
            "content": "Herpes simplex viruses (HSV) are common infections caused mainly by HSV-1 (usually oral) and HSV-2 (usually genital), although either type can affect the mouth or genitals. The virus is highly prevalent and causes lifelong infection associated with a... [2734 chars]",
            "url": "https://www.pharmaceutical-technology.com/analyst-comment/escmid-global-2026-adibelivir-emerges-as-potential-disease-modifying-therapy-for-hsv/",
            "image": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/04/shutterstock_2546579595.jpg",
            "publishedAt": "2026-04-23T19:22:11Z",
            "lang": "en",
            "source": {
                "id": "0dd4b0b6cc151b98e021a8b6653a2c92",
                "name": "Pharmaceutical Technology",
                "url": "https://www.pharmaceutical-technology.com"
            }
        }
    ]
}